Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, International, Prospective, Retrospective, Post Marketing Clinical Follow Up Study to Evaluate the Efficacy and Safety of the Occlutech Patent Ductus Arteriosus Occluder (PDA Occluder) in Patients With Patent Ductus Arteriosus Defects

NCT05264753 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT05264753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, International, Prospective, Retrospective, Post Marketing Clinical Follow Up Study to Evaluate the Efficacy and Safety of the Occlutech Patent Ductus Arteriosus Occluder (PDA Occluder) in Patients With Patent Ductus Arteriosus Defects
Lead sponsor
Occlutech International AB
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2021
Completion date
November 25, 2029
Enrollment
255 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus